PREFERRED STOCK PURCHASE AGREEMENTPreferred Stock Purchase Agreement • December 7th, 2009 • ImmunoCellular Therapeutics, Ltd. • Pharmaceutical preparations • New York
This Preferred Stock Purchase Agreement (“Agreement”) is entered into and effective as of December 3, 2009 (“Effective Date”), by and among ImmunoCellular Therapeutics, Ltd., a Delaware corporation (“Company”), and Socius Capital Group, LLC, a Delaware limited liability company, dba Socius Life Sciences Capital Group, LLC (including its designees, successors and assigns, “Investor”).
